Pages that link to "Q39990884"

The following pages link to Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants (Q39990884):

Displaying 41 items.

• Vaccines for the common cold (Q24201977) (← links)
• Wheeze as an adverse event in pediatric vaccine and drug randomized controlled trials: A systematic review (Q26796334) (← links)
• Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates. (Q27469749) (← links)
• Inactivation of respiratory syncytial virus by zinc finger reactive compounds. (Q33663190) (← links)
• A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5). (Q33690612) (← links)
• Active and passive immunisation against respiratory syncytial virus (Q33782438) (← links)
• Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients (Q33950838) (← links)
• Respiratory syncytial virus vaccines (Q33975330) (← links)
• Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants (Q34100392) (← links)
• Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase (Q34261898) (← links)
• Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. (Q34307704) (← links)
• Prevention of respiratory syncytial virus infections (Q34342190) (← links)
• Feasibility of aerosol vaccination in humans (Q35091812) (← links)
• A General Overview of Viral Vaccine Development (Q35210844) (← links)
• Vaccines for neonatal viral infections: towards a live respiratory syncytial virus vaccine:a study in risk (Q35843602) (← links)
• A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines (Q35874598) (← links)
• Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics (Q36276526) (← links)
• Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. (Q36330347) (← links)
• Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses (Q36422956) (← links)
• Respiratory syncytial virus modified by deletions of the NS2 gene and amino acid S1313 of the L polymerase protein is a temperature-sensitive, live-attenuated vaccine candidate that is phenotypically stable at physiological temperature (Q36607430) (← links)
• Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus (Q36679855) (← links)
• Live-attenuated respiratory syncytial virus vaccines (Q36692801) (← links)
• Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. (Q37071608) (← links)
• Vaccines for the common cold (Q38682527) (← links)
• Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats (Q39585262) (← links)
• Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness (Q39640529) (← links)
• Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus (Q40107962) (← links)
• Pathogenesis of respiratory syncytial virus vaccine-augmented pathology (Q40408366) (← links)
• Respiratory syncytial virus (RSV) disease and prospects for its control (Q40836386) (← links)
• Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine (Q40973791) (← links)
• Respiratory syncytial virus infection in children with congenital heart disease: a review (Q41004650) (← links)
• Viral vaccines: the use of currently available products and future developments (Q41449981) (← links)
• Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines (Q43617842) (← links)
• Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines (Q43746561) (← links)
• Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease (Q45738401) (← links)
• Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine (Q45762897) (← links)
• Correlation of proliferation of lung epithelium with intramuscular sensitization and complement-fixing antibody to respiratory syncytial virus in the golden hamster (Q45791512) (← links)
• Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markers (Q45798887) (← links)
• Respiratory syncytial virus vaccine development (Q56481283) (← links)
• A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats (Q56794662) (← links)
• Chapter 8 Paramyxoviruses (Q93238841) (← links)